Search results
Results from the WOW.Com Content Network
In contrast to NKT cells, NK cells do not express T-cell antigen receptors (TCR) or pan T marker CD3 or surface immunoglobulins (Ig) B cell receptors, but they usually express the surface markers CD16 (FcγRIII) and CD57 in humans, NK1.1 or NK1.2 in C57BL/6 mice.
The term "NK T cells" was first used in mice to define a subset of T cells that expressed the natural killer (NK) cell-associated marker NK1.1 (CD161). It is now generally accepted that the term "NKT cells" refers to CD1d-restricted T cells , present in mice and humans, some of which coexpress a heavily biased, semi-invariant T-cell receptor ...
CD16, also known as FcγRIII, is a cluster of differentiation molecule found on the surface of natural killer cells, neutrophils, monocytes, macrophages, and certain T cells. [ 1 ] [ 2 ] CD16 has been identified as Fc receptors FcγRIIIa (CD16a) and FcγRIIIb (CD16b), which participate in signal transduction. [ 3 ]
An adaptive natural killer (NK) cell or memory-like NK cell is a specialized natural killer cell that has the potential to form immunological memory. [ 1 ] [ 2 ] They can be distinguished from cytotoxic NK (cNK) cells by their receptor expression profile and epigenome. [ 3 ]
140 kD isoform of NCAM (neural cell adhesion molecule), a marker for natural killer cells and some T-lymphocytes CD57: Is expressed by Natural Killer Cells subsets of T cells, B Cells, and Monocytes. Represents a carbohydrate epitope that contains a sulfoglucuronyl residue. CD58
Natural killer (NK) cells are a type of lymphocyte cell involved in the innate immune system's response to viral infection and tumor transformation of host cells. [20] [7] Like T cells, NK cells have many qualities characteristic of the adaptive immune system, including the production of “memory” cells that persist following encounter with antigens and the ability to create a secondary ...
CD2 is a specific marker for T cells and NK cells, and can therefore be used in immunohistochemistry to identify the presence of such cells in tissue sections. The great majority of T cell lymphomas and leukaemias also express CD2, making it possible to use the presence of the antigen to distinguish these conditions from B cell neoplasms.
CD38 was first identified in 1980 as a surface marker (cluster of differentiation) of thymus cell lymphocytes.[10] [11] In 1992 it was additionally described as a surface marker on B cells, monocytes, and natural killer cells (NK cells). [10]